2024年
Ko R, Takahashi K, Kunitomo Y, Tanabe K, Yagishita N, Yamauchi J, Araya N, Nakashima M, Horibe E, Shimizu T, Sato T, Yamano Y.
Performance evaluation of CXCL10 ELISA “cosmic” kit to measure CXCL10 in cerebrospinal fluid of patients with HTLV-1-associated myelopathy.
Clin Exp Neuroimmunol, 2024 Dec in press.
https://doi.org/10.1111/cen3.12822
Izumida Y, Omura T, Fujiwara M, Nukaya S, Yoneyama A, Yabe S, Shiina R, Nakayama S, Muraoka W, Okuno Y, Miyashita S, Ishihara Y, Moriwaki Y, Otani R, Adachi J, Tanabe K, Yamano Y, Takai Y, Honjo M.
Patient-Centric Approach to Personalized Electronic Medical Records via QR code in Japan.
Interactive Journal of Medical Research, 13:e57332, 2024 Dec.
doi: 10.2196/57332
Akamatsu S, Mitsuhashi S, Soga K, Mizukami H, Shiraishi M, Frith MC, Yamano Y.
Targeted nanopore sequencing using the Flongle device to identify mitochondrial DNA variants.
Scientific Reports, 14(1):251612024, 2024 Oct.
doi: 10.1038/s41598-024-75749-8
Sato T, Yagishita N, Araya N, Nakashima M, Horibe E, Takahashi K, Kunitomo Y, Nawa Yukino, Hamaguchi I, and Yamano Y.
Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy.
Viruses, 16(10):1581, 2024 Oct.
https://doi.org/10.3390/v16101581
Yamauchi J, Raghavan D, Imlay H, Jweehan D, Oygen S, Marineci S, Remport A, Hall IE, Molnar MZ.
Deceased Organ Donor HTLV Screening Practices Postelimination of Universal Screening in the United States.
Transplant Direct, 10(10):e1707, 2024 Oct.
DOI: 10.1097/TXD.0000000000001707
Sagara Y, Nakamura H, Shitsuta E, Sagara Y, Uchimaru K, Yamano Y, Watanabe T, Miura K, Matsuzaki K.
Plasma vitamin D levels correlated the pathogenesis of human T-cell leukemia virus type 1-associated diseases.
journal of Medical Virology, 96(9):e29898, 2024 Sep.
https://doi.org/10.1002/jmv.29898
Kuwabara S, Kusunoki S, Kuwahara M, Yamano Y, Nishida Y, Ishida H, Kasuya T, Kupperman E, Lin Q, Frick Glen, Misawa S.
Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
Journal of the Peripheral Nervous System, 29(3):339-349, 2024 Sep.
https://doi.org/10.1111/jns.12646
Takaishi S, Ueda T, Usuki N, Tatsuno K, Yoshie T, Yamano Y.
Age-related differences in diffusion-weighted imaging lesion volume and reversal in patients with successful recanalization after mechanical thrombectomy.
Journal of NeuroInterventional Surgery, :jnis-2024-021922, 2024 Aug.
https://doi.org/10.1136/jnis-2024-021922
Imai T, Mitsuhashi S, Isahaya K, Shibata S, Kawai Y, OMAE Y, Yamano Y.
Wilson disease (novel ATP7B variants) with concomitant FLNC-related cardiomyopathy.
Human Genome Variation, 11(1):34, 2024 Aug.
https://doi.org/10.1038/s41439-024-00283-y
Itabashi K, Miyazawa T, Nakashima M, Makiyama J, Uchimaru Kaoru.
Transmission of Human T-Cell Leukemia Virus Type 1 From Mother to Child and Adult T-Cell Leukemia/Lymphoma.
Comprehensive Hematology and Stem Cell Research, 330-359, 2024 Aug.
https://doi.org/10.1016/B978-0-443-15717-2.00051-2
Iijima N, Sakurai K, Ko R, Isahaya K, Yamano Y.
Successful treatment with plasmapheresis of severe Bickerstaff brainstem encephalitis with high cerebrospinal fluid CXCL-10 levels after COVID-19 infection.
Clin Exp Neuroimmunol, 16(1):30-34, 2024 Jul.
https://doi.org/10.1111/cen3.12806
Shoji H, Yamano Y.
The history of the Japanese Society for Neuro-infectious Diseases: Foundation, objectives, and legacy.
Intractable & Rare Diseases Research, 13(2):129-132, 2024 May.
https://doi.org/10.5582/irdr.2024.01008
Mizukami H, Shiraishi M, Hino S, Kaburagi M, Matsumoto H, Hagiwara Yuta and Yamano Y.
Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson’s Disease.
Brain Sci, 14(6):524, 2024 Apr.
https://doi.org/10.3390/brainsci14060524
Kaburagi K, Hagiwara Y, Tachikawa K, Miyake N, Akiyama H, Kawai Y, Omae Y, Tokunaga Y, Yamano Y, Shimizu T, Mitsuhashi T.
A Novel NODAL variant in a young embolic stroke patient with visceral heterotaxy.
BMC Neurology, 24(1):119, 2024 Apr.
https://doi.org/10.21203/rs.3.rs-2847400/v1
Imoto K, Yamamoto H, Ohkawa C, Shimada N, Ikuzawa R, Takeda H, Ohhara T, Kojima Y, Furuya N, Motoyoshi A, Migita O, Kuga A, Keira T, Wakamatsu H, Sato T, Oike N, Koike J, Yamano Y, Sunakawa Y.
An approach for improvement of the accuracy of cancer gene panel testing.
Int J Clin Oncol, 29(5):571-581, 2024 Mar.
https://doi.org/10.1007/s10147-024-02483-6
Sato T, Nagai M, Watanabe O, Misu T, Takenouchi N, Ohkubo R, Ishihara S, Tsuboi Y, Katsuno M, Nakagawa M, Matsushita T, Aso Yasuhiro, Matsuura E, Tokashiki T, Mukaino A, Adachi H, Nakanishi K, Yamaguchi Y, Yamaguchi S, Yamano Y.
Multicenter, randomized, double‑blind, placebo‑controlled phase 3 study of mogamulizumab with open‑label extension study in a minimum number of patients with human T‑cell leukemia virus type‑1‑associated myelopathy.
Journal of Neurology, 271(6):3471-3485, 2024 Mar.
https://doi.org/10.1007/s00415-024-12239-x
Yamagishi M, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T, Makiyama J, Suzuki K, Seki M, Abe K, Imamura K, Watanabe E, Tsuchiya K, Yasumatsu I, Takayama G, Hizukuri Y, Ito K, Taira Y, Nannya Y, Tojo A, Watanabe T, Tsutsumi S, Suzuki Y, Uchimaru K.
Mechanisms of action and resistance in histone methylation-targeted therapy.
Nature, 627(8002):221-228, 2024 Mar.
https://doi.org/10.1038/s41586-024-07103-x
Araga T, Ueda T, Yoshie T, Takao N, Ohtsubo H, Tatsuno K, Usuki N, Takaishi S, and Yamano Y.
Improvement of cerebral blood flow after balloon angioplasty and stenting for symptomatic middle cerebral artery stenosis.
Interventional Neuroradiology, 2024 Feb Online First.
https://doi.org/10.1177/15910199241231148
Takao N, Yagishita N, Araya N, Aratani S, Yamauchi J, Takahashi K, Kunitomo Y, Sato T, Nakamori M, Kawai Y, Omae Y, Tokunaga K, Matsuda Fumihiko, Mitsuhashi S and Yamano Y.
Large-Scale Whole-Genome Analysis of HTLV-1–Associated Myelopathy Identified Hereditary Spastic Paraplegias.
Neurology Genetics, 10(1): e200108, 2024 Jan.
https://doi.org/10.1212/NXG.0000000000200108
山野 嘉久.
希少難病のドラッグラグ・ドラッグロスの解決に資する基盤を目指して～難病プラットフォームについて～
神経治療学, 41 (6):191, 2024年10月.
https://doi.org/10.15082/jsnt.41.6_S191
山野 嘉久.
第27 回日本神経感染症学会 総会・学術大会を終えて
新しい神経感染症学の創造～パンデミック克服後の未来を描く～
NEUROINFECTION, 29(1):1, 2024年9月.
https://doi.org/10.34397/jsnd.29.1_1
山野 嘉久.
難病領域におけるレジストリ活用の動向～難病プラットフォームについて～
神経治療学, 41(3):277-279, 2024年9月.
https://doi.org/10.15082/jsnt.41.3_277
眞木 二葉, 山野 嘉久.
経頭蓋MRガイド下集束超音波治療の実際
神経治療学, 41(2):85-89, 2024年7月.
https://doi.org/10.15082/jsnt.41.2_85
星野 俊, 永沼 秀崇, 石井 誠也, 桒田 千尋, 清水 高弘, 秋山 久尚, 山野 嘉久.
フィナステリド服用中に脳静脈血栓症と脳梗塞を発症した1例
日本頭痛学会誌, 50(4):731-734, 2024年6月.
https://doi.org/10.50860/jjho.50.4_731
山野嘉久.
HTLV-1関連脊髄症（HAM).
実践シェアード・ディシジョンメイキング, 218-224, 2024年6月.
